| 别名 | ; |
双硫腙银复合物
Dithizone Silver Complex （订货以英文为准）
编号：D155114
CAS号：36539-86-3
分子式：C13H11AGN4S
分子量：363.19
| 产品名称 | Dithizone Silver Complex |
| 中文名称 | 双硫腙银复合物 |
| CAS号 | 36539-86-3 |
| MDL编码 | D155114 |
| 分子式（M.F.） | C13H11AGN4S |
| 分子量（M.W.） | 363.19 |
| 储存条件 | RT |
| 标识符号 | https://www.aladdin-e.com/images/ghs/ghs05.jpg,https://www.aladdin-e.com/images/ghs/ghs07.jpg |
| 信号词 | Danger |
| 危害声明 | H302,H318 |
| 警示性声明 | P280,P305+P351+P338 |
| 个人防护设备 | Eyeshields,Faceshields,Gloves |
| 风险声明 (欧洲) | R22;R31 |
| 安全声明（欧洲） | S25;S46 |
| 危害码（欧洲） | Xn |
| 是否危化品 | 一般危化品 |
技术规格
| Background: | The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Acts by mediating ubiquitin E3 ligase activity that is required for its tumor suppressor function. Plays a central role in DNA repair by facilitating cellular response to DNA repair. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation |
| Applications: | WB, IHC |
| Name of antibody: | BRCA1 (Phospho-Ser1423) |
| Immunogen: | Synthetic peptide of human BRCA1 (Phospho-Ser1423) |
| Full name: | breast cancer 1, early onset (Phospho-Ser1423) |
| Synonyms： | IRIS; PSCP; BRCAI; BRCC1; PNCA4; RNF53; BROVCA1; PPP1R53 |
| SwissProt: | P38398 |
| IHC positive control: | Human breast carcinoma |
| IHC Recommend dilution: | 50-100 |
| WB Predicted band size: | 208 kDa |
| WB Positive control: | HT29 cells untreated or treated with Anisomycin |
| WB Recommended dilution: | 500-1000 |
搜索质检报告(COA)
搜索MSDS
相关产品
党沛 
